PATENT CLAIM ANALYSIS

Application Number: 15936169
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "325000"]

Abstract:
The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof.

Claim (Index 32):
A method for triggering an immune response in a cat, against cells that overexpress telomerase, which method comprises administering to the cat an effective amount of the nucleic acid molecule of  claim 20 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.15385
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780613', '14780652', '15032966', '11974067', '11826134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6862325846068061
- 35 USC 102 Novelty (BERT): 0.6299046543481452
- Combined Prediction Score: 0.6805997915809401
- Mean Citation Score: 425.556528
- Max Citation Score: 634.4167
- Similarity Product: 538.7348323353111

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test